MAPK1 and melanoma: However, it was also possible that PN could elevate the MITF level because it is an inhibitor of NF-κB and the gene expression reciprocity between NF-κB and MITF was reported in melanoma cell lines as modulating intrinsic sensitivity of melanomas to inhibitors of the BRAF/MEK/ERK pathway [37].